ATE447174T1 - Verfahren zum direkten nachweis einzelner methotrexatmetabolite - Google Patents
Verfahren zum direkten nachweis einzelner methotrexatmetaboliteInfo
- Publication number
- ATE447174T1 ATE447174T1 AT04716493T AT04716493T ATE447174T1 AT E447174 T1 ATE447174 T1 AT E447174T1 AT 04716493 T AT04716493 T AT 04716493T AT 04716493 T AT04716493 T AT 04716493T AT E447174 T1 ATE447174 T1 AT E447174T1
- Authority
- AT
- Austria
- Prior art keywords
- mtxpg
- direct detection
- determining
- level
- metabolite
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- LWCXZSDKANNOAR-UHFFFAOYSA-N 4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoic acid Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(O)=O)C=C1 LWCXZSDKANNOAR-UHFFFAOYSA-N 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 108700009082 methotrexate polyglutamate Proteins 0.000 abstract 11
- 230000001413 cellular effect Effects 0.000 abstract 3
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 abstract 1
- 229960000485 methotrexate Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/384,066 US6921667B2 (en) | 2003-03-07 | 2003-03-07 | Methods for direct detection of individual methotrexate metabolites |
| PCT/US2004/006312 WO2004081521A2 (en) | 2003-03-07 | 2004-03-02 | Methods for direct detection of individual methotrexate metabolites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE447174T1 true ATE447174T1 (de) | 2009-11-15 |
Family
ID=32927184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04716493T ATE447174T1 (de) | 2003-03-07 | 2004-03-02 | Verfahren zum direkten nachweis einzelner methotrexatmetabolite |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6921667B2 (de) |
| EP (2) | EP1604203B1 (de) |
| JP (1) | JP2006520914A (de) |
| AT (1) | ATE447174T1 (de) |
| AU (1) | AU2004219711B2 (de) |
| CA (1) | CA2517709C (de) |
| DE (1) | DE602004023824D1 (de) |
| DK (1) | DK1604203T3 (de) |
| ES (1) | ES2335767T3 (de) |
| WO (1) | WO2004081521A2 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7563590B2 (en) * | 2002-08-30 | 2009-07-21 | Cypress Bioscience Inc. | Methods of quantifying methotrexate metabolites |
| US7582282B2 (en) * | 2003-08-29 | 2009-09-01 | Prometheus Laboratories Inc. | Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics |
| SE0303526D0 (sv) * | 2003-12-22 | 2003-12-22 | Biofol Ab | Chemotherapeutic agents |
| US20060286571A1 (en) | 2005-04-28 | 2006-12-21 | Prometheus Laboratories, Inc. | Methods of predicting methotrexate efficacy and toxicity |
| US9770414B2 (en) * | 2010-05-13 | 2017-09-26 | Pacira Pharmaceuticals, Inc. | Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent |
| WO2018031967A1 (en) | 2016-08-12 | 2018-02-15 | L.E.A.F. Holdings Group Llc | Polyglutamated antifolates and uses thereof |
| KR102708209B1 (ko) | 2016-08-12 | 2024-09-20 | 엘.이.에이.에프. 홀딩스 그룹 엘엘씨. | 알파 및 감마-d 폴리글루타메이트화 항엽산 및 이의 용도 |
| WO2019157138A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated pemetrexed and uses thereof |
| CN111954529A (zh) | 2018-02-07 | 2020-11-17 | L.E.A.F.控股集团公司 | α聚谷氨酸化氨甲蝶呤及其用途 |
| US12246019B2 (en) | 2018-02-07 | 2025-03-11 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated lometrexol and uses thereof |
| CA3090483A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated pemetrexed and uses thereof |
| CA3090389A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated raltitrexed and uses thereof |
| US12310966B2 (en) | 2018-02-07 | 2025-05-27 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated aminopterin and uses thereof |
| WO2019157140A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated raltitrexed and uses thereof |
| CN111867593A (zh) | 2018-02-07 | 2020-10-30 | L.E.A.F.控股集团公司 | α聚谷氨酸化抗叶酸剂及其用途 |
| CA3090387A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated pralatrexate and uses thereof |
| JP7514533B2 (ja) | 2018-02-07 | 2024-07-11 | エル．イー．エー．エフ． ホールディングス グループ エルエルシー | アルファポリグルタミン酸化テトラヒドロ葉酸およびその使用 |
| WO2019160733A1 (en) | 2018-02-14 | 2019-08-22 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated methotrexate and uses thereof |
| EP3755335A4 (de) | 2018-02-14 | 2022-06-22 | L.E.A.F Holdings Group LLC | Gamma-polyglutamierte tetrahydrofolate und deren verwendungen |
| EP3752158A4 (de) | 2018-02-14 | 2022-03-09 | L.E.A.F Holdings Group LLC | Gamma-polyglutamiertes aminopterin und verwendungen davon |
| EP3752156A4 (de) | 2018-02-14 | 2021-10-27 | L.E.A.F Holdings Group LLC | Gamma-polyglutamiertse pralatrexat und verwendungen davon |
| WO2019160734A1 (en) | 2018-02-14 | 2019-08-22 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated lometrexol and uses thereof |
| CN110320302A (zh) * | 2019-07-23 | 2019-10-11 | 北京陆道培生物技术有限公司 | 快速测定甲氨蝶呤血药浓度的方法 |
| WO2021026310A1 (en) * | 2019-08-06 | 2021-02-11 | L.E.A.F. Holdings Group Llc | Processes of preparing polyglutamated antifolates and uses of their compositions |
| CN111551659B (zh) * | 2020-05-14 | 2022-11-18 | 上海大学 | 污水处理厂污泥中抗癌药物的快速检测分析方法 |
| CN112415117A (zh) * | 2020-12-04 | 2021-02-26 | 北京和合医学诊断技术股份有限公司 | 甲氨蝶呤的检测方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2512572A (en) | 1950-06-20 | Substituted pteridines and method | ||
| US3989703A (en) | 1974-03-22 | 1976-11-02 | Institutul Oncologic | Process of preparing N[p-{[(2,4-diamino-6-pteridyl)-methyl]N10 -methylamino}-benzoyl]-glutamic acid |
| US4106488A (en) | 1974-08-20 | 1978-08-15 | Robert Thomas Gordon | Cancer treatment method |
| US3892801A (en) | 1974-09-11 | 1975-07-01 | American Cyanamid Co | Method for preparing alkali salts of p-methylaminobenzoylglutamic acid |
| US4079056A (en) | 1975-03-31 | 1978-03-14 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Method of making pteridine compounds |
| US4057548A (en) | 1975-11-11 | 1977-11-08 | Jacek Wiecko | Process for preparing methotrexate or an N-substituted derivative thereof and/or a di (lower) alkyl ester thereof and precursor therefor |
| US4067867A (en) | 1976-03-30 | 1978-01-10 | Jacek Wiecko | Process for preparing pyrazine precursor of methotrexate or an N-substituted derivative thereof and/or a di(lower)alkyl ester thereof |
| US4080325A (en) | 1976-11-17 | 1978-03-21 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Synthesis of methotrexate |
| CH630380A5 (de) | 1977-08-12 | 1982-06-15 | Lonza Ag | Verfahren zur herstellung von l-methotrexat. |
| US4136101A (en) | 1978-02-03 | 1979-01-23 | American Cyanamid Company | Process for preparing dialkyl (p-aminobenzoyl) glutamates |
| US4306064A (en) | 1980-03-25 | 1981-12-15 | Ellard James A | Synthesis of 2,4-diamino-6-hydroxymethylpteridine |
| US4421913A (en) | 1980-04-23 | 1983-12-20 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Separation of triphenylphosphine oxide from methotrexate ester and purification of said ester |
| US4374987A (en) | 1980-08-14 | 1983-02-22 | American Cyanamid Company | Process for the preparation of high purity methotrexate and derivatives thereof |
| US4558690A (en) | 1982-01-26 | 1985-12-17 | University Of Scranton | Method of administration of chemotherapy to tumors |
| US4662359A (en) | 1983-08-12 | 1987-05-05 | Robert T. Gordon | Use of magnetic susceptibility probes in the treatment of cancer |
| FR2590255B1 (fr) | 1985-11-19 | 1987-12-24 | Rhone Poulenc Sante | Procede de preparation de derives de la pteridine |
| US7563590B2 (en) * | 2002-08-30 | 2009-07-21 | Cypress Bioscience Inc. | Methods of quantifying methotrexate metabolites |
-
2003
- 2003-03-07 US US10/384,066 patent/US6921667B2/en not_active Expired - Lifetime
-
2004
- 2004-03-02 DE DE602004023824T patent/DE602004023824D1/de not_active Expired - Lifetime
- 2004-03-02 EP EP04716493A patent/EP1604203B1/de not_active Expired - Lifetime
- 2004-03-02 CA CA2517709A patent/CA2517709C/en not_active Expired - Fee Related
- 2004-03-02 WO PCT/US2004/006312 patent/WO2004081521A2/en not_active Ceased
- 2004-03-02 ES ES04716493T patent/ES2335767T3/es not_active Expired - Lifetime
- 2004-03-02 AT AT04716493T patent/ATE447174T1/de not_active IP Right Cessation
- 2004-03-02 JP JP2006508989A patent/JP2006520914A/ja active Pending
- 2004-03-02 AU AU2004219711A patent/AU2004219711B2/en not_active Ceased
- 2004-03-02 EP EP09013484A patent/EP2148199A1/de not_active Withdrawn
- 2004-03-02 DK DK04716493.4T patent/DK1604203T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2517709C (en) | 2011-11-15 |
| EP1604203B1 (de) | 2009-10-28 |
| AU2004219711B2 (en) | 2010-04-22 |
| US6921667B2 (en) | 2005-07-26 |
| ES2335767T3 (es) | 2010-04-05 |
| EP1604203A2 (de) | 2005-12-14 |
| HK1079571A1 (en) | 2006-04-07 |
| DE602004023824D1 (de) | 2009-12-10 |
| JP2006520914A (ja) | 2006-09-14 |
| DK1604203T3 (da) | 2010-03-01 |
| AU2004219711A1 (en) | 2004-09-23 |
| CA2517709A1 (en) | 2004-09-23 |
| WO2004081521A2 (en) | 2004-09-23 |
| EP1604203A4 (de) | 2007-07-11 |
| EP2148199A1 (de) | 2010-01-27 |
| US20040175834A1 (en) | 2004-09-09 |
| WO2004081521A3 (en) | 2004-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE447174T1 (de) | Verfahren zum direkten nachweis einzelner methotrexatmetabolite | |
| DE60223561D1 (de) | Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon | |
| ATE438737T1 (de) | Verfahren für den nachweis von erkrankungen | |
| ATE431427T1 (de) | Verbessertes verfahren zum nachweis von atp | |
| ATE271691T1 (de) | Verfahren zum nachweis der effektivität einer krebstherapie | |
| ATE508360T1 (de) | Verfahren, vorrichtungen und computerprogramme zum verifizieren der integrität einer sonde | |
| ATE420204T1 (de) | Verfahren zur detektion von erkrankungen | |
| DE602004012200D1 (de) | Vorrichtung zum Sortieren von Postgut in eine Reihenfolge | |
| CY1111229T1 (el) | Μεθοδος προσδιορισμου ρευματοειδους αρθριτιδας με μετρηση αντι-ccp και ιντερλευκλινης 6 | |
| ATE408639T1 (de) | Zusammensetzungen und verfahren zum oberflächeneindrücken | |
| ATE476525T1 (de) | Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern | |
| DE60321356D1 (de) | Verfahren zur diagnostik von eierstock endometriose | |
| DE60124975D1 (de) | Automatischer apparat zum messen von wassertoxizität | |
| DE60328055D1 (de) | Verfahren zum nachweis von pathogenen mykobakterien in klinischen proben | |
| EP1691155A4 (de) | Verbrennungsgasextraktionssonde und verbrennungsgasbehandlungsverfahren | |
| ATE487797T1 (de) | Verfahren zum nachweis von transferase- enzymaktivität | |
| DK1560929T3 (da) | Polynucleotider til amplifikation og detektion af chlamydia trachomatis og neisseria gonore | |
| BR0317612A (pt) | Identificação, monitoração e tratamento de doença infecciosa e caracterização de condições inflamatórias relacionadas com doença infecciosa empregando perfis de expressão de gene | |
| DE60216570D1 (de) | Verfahren zum nachweis von alzheimer-krankheit | |
| DE602004026439D1 (de) | Lp-pla2-aktivitätstest mit hohem durchsatz | |
| DE50207850D1 (de) | Biosensor und verfahren zum erfassen von nukleinsäuren mittels mindestens zwei einheiten zum immobilisieren von nukleinsäuren | |
| ATE441113T1 (de) | Verfahren zum nachweis von endotoxin | |
| ATE415492T1 (de) | Verfahren zum identifizieren von makrocyclischen polyketiden | |
| ATE524556T1 (de) | Verfahren zur zyklischen nukleotid-bestimmung | |
| DE60327776D1 (de) | Sonden zum nachweis von tumorzellen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |